Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan

Journal of Gastroenterology

Volumn 35, Issue 8, 2000, Pages 583-592

  Azuma, Naoki ^a   Endo, Takao ^a   Arimura, Yoshiaki ^a   Motoya, Satoshi ^a   Itoh, Fumio ^a   Hinoda, Yuji ^b   Irimura, Tatsuro ^c   Hosokawa, Masao ^d   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Keiyukai Sapporo Hospital   (Japan)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Mucin; Sulfo Lewisa

Indexed keywords

ANTIGEN; EPITOPE; MONOCLONAL ANTIBODY; MUCIN; STOMACH MUCIN;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BARRETT ESOPHAGUS; COLON; CONTROLLED STUDY; ESOPHAGOSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SMALL INTESTINE; STOMACH;

EID: 0033845662     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350070057     Document Type: Article

References (44)

1. Barrett's esophagus development of dysplasia and adenocarcinoma
2. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years
3. Blood-group phenotype, sulfomucin, and Helicobacter pylori in Barrett's esophagus
4. Surgical treatment of Barrett's esophagus
5. Prospective long term endoscopic and histogical follow-up of short segment Barrett's esophagus: Comparison with traditional long segment Barrett's esophagus
6. Short-segment Barrett's esophagus: A prevalent complication of gastroesophageal reflux disease with malignant potential
7. Increasing incidence of Barrett's oesophagus: Education, enthusias, or epidemiology?
8. Increasing incidence of adenocarcinoma of esophagus and esophagogastric junction
9. Columnar epithelial lined oesophagus (CELO) or Barrett's oesophagus. Mucin histochemistry, dysplasia, and invasive adenocarcinoma
10. Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus): A prospective biopsy study
11. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma
12. Endoscopic observation of longitudinal vessels at the lower esophagus and its clinical significance
13. An endoscopic recognition of the atrophic border and its significance in chronic gastritis
14. Clinical study of esophageal hiatal hernia: Diagnostic criteria and degree classification of hiatal hernia
15. The endoscopic assessment of esophagitis: A progress report on observer agreement
16. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus
17. Double muscularis mucosae in Barrett's esophagus
18. Monoclonal antibody against human colonic sulfomucin: Immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastasis
19. Human colonic sulfomucin identified by a specific monoclonal antibody
20. Novel carbohydrate specificity of monoclonal antibody 91.9H prepared against human colonic sulfomucin: Recognition of Sulfo-Lewis a structure
21. Expression of sulfated carbohydrate chains detected by monoclonal antibody 91.9H in human gastric cancer tissues
22. Oncofetal expression of the human intestinal mucin glycoprotein antigens in gastrointestinal epithelium defined by monoclonal antibodies
23. Characterisation of the tumor-associated carbohydrate epitope recognized by monoclonal antibody 4D3
24. Oncofetal mucin M1 epitope family: Characterization and expression during colonic carcinogenesis
25. Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene
26. Immunohistological and immunochemical characterization of a novel pancreatic cancer-associated antigen MUSE11
27. Second generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer
28. Immunohistological characterization of mucin epitopes by pre-treatment of gastro-intestinal sections with periodic acid
29. Incidence of Barrett's epithelium and its association with reflux esophagitis
30. Diagnosis of short segment Barrett's esophagus
31. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data
32. Significance of short-segment Barrett's esophagus
33. Short segment Barrett's esophagus: Clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia
34. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus
35. The mucin profils of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma
36. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression
37. Mucin histochemical study of differentiated adenocarcinoma of stomach
38. Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus): A prospective biopsy study
39. Histological and histochemical changes in the columnar lined (Barrett's) esophagus
40. Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk
41. Sulfated blood group Lewis a. A superior oligosaccharide ligand for human E-selectin
42. Valency dependent patterns of binding of human L-selectin toward sialyl and sulfated oligosaccharides of Le(a) and Le(x) types: Relevance to anti-adhesion therapeutics
43. High affinity binding of the leucocyte adhesion molecule L-selectin to 3'-sulphated-Le(a) and -Le(x) oligosaccharides and predominance of sulphate in this interaction demonstrated by binding studies with a oligosaccharides
44. a carbohydrate epitopes on human colon carcinoma cells